LON:POLX

Polarean Imaging (POLX) Share Forecast, Price & News

GBX 10.10

+0.70 (+7.45%)

(As of 09/29/2023 ET)

Compare

Today's Range: 9.40
▼
10.39
50-Day Range: 9.38
▼
22.50
52-Week Range: 9
▼
84.20

Volume: 1.77 million shs
Average Volume: 723,296 shs
Market Capitalization: £21.80 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Profile Chart Competitors Headlines

About Polarean Imaging (LON:POLX) Stock

Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.

POLX Price History

30 days | 90 days | 365 days | Advanced Chart

POLX Stock News Headlines

September 27, 2023 | proactiveinvestors.com

Polarean Imaging appoints new non-executive director

August 29, 2023 | finance.yahoo.com

CMS grants reimbursement code for the Polarean XENOVIEW™ MRI Technology

September 29, 2023 | Behind the Markets (Ad)

6.5 Million Americans Are DESPERATE for This New Drug from One Tiny Company

Decades of pent-up demand for this "first-ever" treatment could give you WINDFALL PROFITS... Click here to learn more >>>

July 10, 2023 | finance.yahoo.com

We're Keeping An Eye On Polarean Imaging's (LON:POLX) Cash Burn Rate

June 22, 2023 | bizjournals.com

Durham medtech names new CEO to steer commercial launch

June 21, 2023 | finanznachrichten.de

Polarean Imaging plc: Appointment of Dr. Christopher von Jako as new CEO

May 29, 2023 | finance.yahoo.com

Recent 10% pullback isn't enough to hurt long-term Polarean Imaging (LON:POLX) shareholders, they're still up 59% over 5 years

May 26, 2023 | proactiveinvestors.com

Polarean Imaging focused on gaining commercial traction for XENOVIEW

September 29, 2023 | Altimetry (Ad)

WARNING: Seven millionaires to trigger sudden market panic?

The next major selloff could be just days away…And seven powerful (yet completely unknown) insiders will be behind it all – and help corporate executives make a killing as it plays out. Here’s the full story.

May 19, 2023 | msn.com

This penny stock has halved in 2023 to 28p! Should I buy?

May 12, 2023 | marketwatch.com

First clinical scan using XENOVIEW conducted at Cincinnati Children's Hospital Medical Center

May 11, 2023 | finance.yahoo.com

First clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical Center

April 17, 2023 | proactiveinvestors.com

Polarean Imaging hires consultant to support commercial planning

March 14, 2023 | proactiveinvestors.com

Polarean Imaging gains access to funds after new bridge bank is formed; share suspension lifted

March 13, 2023 | finance.yahoo.com

U.K. tech, life sciences firms outline exposure to failed SVB

February 13, 2023 | proactiveinvestors.com

Polarean Imaging looking to gain commercial traction for its XENOVIEW

December 28, 2022 | proactiveinvestors.com

Polarean Imaging PLC surges as XENOVIEW gets FDA green light

December 28, 2022 | proactiveinvestors.com

Polarean Imaging surges as XENOVIEW gets FDA green light

November 29, 2022 | finance.yahoo.com

Polarean Imaging plc (LON:POLX) has caught the attention of institutional investors who hold a sizeable 44% stake

October 27, 2022 | finance.yahoo.com

Polarean Imaging's (LON:POLX) investors will be pleased with their notable 96% return over the last three years

September 22, 2022 | proactiveinvestors.com

Polarean Imaging says US FDA requests additional information from manufacturing partner of its xenon-129 gas blend drug

September 6, 2022 | finance.yahoo.com

Polarean Imaging plc (POLX.L)

August 31, 2022 | marketwatch.com

Polarean Imaging 1H Pretax Loss Widened on Greater Expenses, FX Losses

July 24, 2022 | finance.yahoo.com

Here's Why We're Not Too Worried About Polarean Imaging's (LON:POLX) Cash Burn Situation

June 19, 2022 | finance.yahoo.com

What Is The Ownership Structure Like For Polarean Imaging plc (LON:POLX)?

April 20, 2022 | proactiveinvestors.com

Polarean Imaging says US regulator accepts updated submission

April 14, 2022 | proactiveinvestors.com

Polarean Imaging appoints former GE Healthcare exec as an independent director

See More Headlines

Receive POLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Polarean Imaging and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Medical Devices
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:POLX
CUSIP: N/A
CIK: N/A
Web: www.polarean.com
Phone: 919 206 7900
Fax: N/A
Employees: 28
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.05)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-14,340,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -75.33%
Return on Assets: -40.85%

Debt

Debt-to-Equity Ratio: 2.30
Current Ratio: 5.50
Quick Ratio: 9.80

Sales & Book Value

Annual Sales: £1.03 million
Price / Sales: 21.43
Cash Flow: GBX 2.08 per share
Price / Cash Flow: 4.93
Book Value: GBX 6 per share
Price / Book: 1.70

Miscellaneous

Outstanding Shares: 215,850,000
Free Float: N/A
Market Cap: £22.07 million
Optionable: Not Optionable
Beta: 0.76

The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Kenneth Paul West (Age 66)
Chairman
Comp: $38.25k

Dr. Bastiaan Driehuys Ph.D. (Age 54)
Founder, CTO & Director
Comp: $43.25k

Mr. Charles Fremont Osborne Jr. (Age 57)
CFO & Director
Comp: $315.42k

Mr. Clairis Richard Hullihen (Age 70)
Exec. Officer
Comp: $348.52k

Dr. Christopher Richard Von Jako Ph.D. (Age 53)
CEO & Director

Mr. Neil Wadehra (Age 43)
VP of Operations

Mr. Alex Dusek (Age 56)
Chief Commercial Officer

Mr. Stephen Austin
Company Sec.

Key Competitors

View All Competitors

POLX Stock - Frequently Asked Questions

How have POLX shares performed in 2023?: Polarean Imaging's stock was trading at GBX 56 at the beginning of 2023. Since then, POLX stock has decreased by 81.7% and is now trading at GBX 10.23.
View the best growth stocks for 2023 here.
What other stocks do shareholders of Polarean Imaging own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Polarean Imaging investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP).
What is Polarean Imaging's stock symbol?: Polarean Imaging trades on the London Stock Exchange (LON) under the ticker symbol "POLX."

How do I buy shares of Polarean Imaging?: Shares of POLX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is Polarean Imaging's stock price today?: One share of POLX stock can currently be purchased for approximately GBX 10.23.
How much money does Polarean Imaging make?: Polarean Imaging (LON:POLX) has a market capitalization of £22.07 million and generates £1.03 million in revenue each year. The company earns £-14,340,000.00 in net income (profit) each year or GBX (0.05) on an earnings per share basis.
How can I contact Polarean Imaging?: Polarean Imaging's mailing address is 2500 Meridian Parkway, Suite 175, Durham, NC 27713, United States. The official website for the company is www.polarean.com. The company can be reached via phone at 919 206 7900.

This page (LON:POLX) was last updated on 9/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial